How to Help Your Patients Find Mar-Cof CG in Stock: A Provider's Guide

When you write a prescription for Mar-Cof CG and your patient comes back unable to fill it, it creates a frustrating cycle for both of you. They need relief from a persistent cough, and you need them to be able to get the medication you've determined is clinically appropriate.

This guide outlines practical strategies for prescribers — at the point of care and beyond — to help patients successfully navigate the challenge of filling Schedule V codeine prescriptions like Mar-Cof CG in 2026.

Why Patients Struggle to Fill Mar-Cof CG Prescriptions

Mar-Cof CG (codeine phosphate 7.5 mg / guaifenesin 225 mg per 5 mL) is a Schedule V controlled substance. Unlike most common medications, pharmacies must maintain DEA compliance records for every Schedule V drug they stock. For low-volume products like codeine cough syrups, many pharmacies have reduced or eliminated stocking entirely.

The result: a patient may receive a valid, appropriately-written prescription and still spend 30–60 minutes calling pharmacies before finding one that has it in stock. For patients who are already ill, this is a significant burden. There is no active FDA shortage, but the structural availability challenges are real.

Strategy 1: Write for Generic to Improve Fill Rate

When clinically appropriate, prescribe for the generic: "codeine phosphate/guaifenesin oral solution 7.5 mg/225 mg per 5 mL." Generic formulations of this product are manufactured by multiple companies and may be available at pharmacies that don't carry the Mar-Cof CG brand specifically.

If you specifically intend Mar-Cof CG for its alcohol-free and sugar-free properties (relevant for patients with diabetes or alcohol contraindications), note that in the prescription — but be aware that most generic formulations also share these properties.

Strategy 2: Direct Patients to a Pharmacy Search Tool

Rather than having patients call pharmacies blindly, recommend medfinder.com. medfinder calls pharmacies on the patient's behalf to check which ones have their specific medication in stock, then texts them the results. This is especially valuable for controlled substances like Mar-Cof CG, where real-time online inventory data isn't available.

Suggesting this tool at the point of prescription can dramatically reduce the "pharmacy runaround" your patients experience and improve adherence to the treatment you've recommended.

Strategy 3: Identify Your High-Volume Local Pharmacies for Schedule V

Over time, it's worth identifying which 2–3 pharmacies in your area reliably stock Schedule V cough preparations. Large chain pharmacies (CVS, Walgreens, Walmart) typically have the most consistent controlled substance inventory. Once identified, you can share this information with patients at the point of prescription.

Some practices maintain a short list of "controlled substance-friendly" pharmacies to give patients along with prescriptions for Schedule II–V medications. This simple measure can prevent a significant percentage of access complaints.

Strategy 4: Have a Ready Backup Prescription

In practices where patients regularly struggle to fill controlled substance cough preparations, consider having a clinically equivalent backup prescription ready. For example, benzonatate 200 mg TID + guaifenesin 600 mg BID provides similar dual-action (suppress + expectorant) coverage and is easily filled at any pharmacy without controlled substance complications.

Benzonatate is not a controlled substance, is widely stocked, and costs a few dollars generic. If your patient can't fill Mar-Cof CG within 24 hours, having this backup available avoids an extra office visit or phone call.

Strategy 5: Consider Compounding for High-Risk Patients

For patients with specific formulation needs (e.g., a particular strength, lactose-free, or different vehicle) who cannot find Mar-Cof CG, a compounding pharmacy can prepare a custom codeine/guaifenesin solution. This requires a prescription written specifically for the compounded formulation.

Most compounding pharmacies are accredited and can typically prepare controlled substance formulations if they have the appropriate DEA registration. Turnaround is usually 1–2 business days.

Documentation and Safety Reminders

Regardless of which strategy you use, ensure proper documentation and patient counseling for any codeine prescription:

• Document the indication and short-term nature of use in the chart
• Review the patient's PDMP report before prescribing any controlled substance
• Counsel on respiratory depression risk when combined with other CNS depressants
• Do not prescribe for patients under 18 per FDA guidance
• Provide instructions on proper disposal per DEA guidelines if unused medication remains

Summary: A Practical Checklist for Providers

1. Consider writing for generic codeine/guaifenesin to improve fill rate
2. Recommend medfinder to eliminate the pharmacy-calling burden
3. Build a local list of pharmacies that reliably stock Schedule V products
4. Have a backup benzonatate + guaifenesin prescription ready for patients who can't fill
5. Ensure all codeine prescriptions follow REMS counseling and documentation requirements